Page last updated: 2024-08-26

isophosphamide mustard and Adenocarcinoma

isophosphamide mustard has been researched along with Adenocarcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Corbett, TH; Dykes, DJ; Struck, RF; Suling, WJ; Trader, MW1
Hansen, L; Harland, SJ; Hartley, JM; Nicholson, PW; Pasini, F; Souhami, RL1

Other Studies

2 other study(ies) available for isophosphamide mustard and Adenocarcinoma

ArticleYear
Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide.
    British journal of cancer, 1983, Volume: 47, Issue:1

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Survival; Colonic Neoplasms; Cyclophosphamide; Female; Ifosfamide; Leukemia, Experimental; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Neoplasms, Experimental; Phosphoramide Mustards; Rats; Sarcoma, Yoshida

1983
Metabolism of ifosfamide during a 3 day infusion.
    British journal of cancer, 1994, Volume: 69, Issue:5

    Topics: Adenocarcinoma; Chromatography, Thin Layer; Female; Humans; Ifosfamide; Male; Neuroectodermal Tumors, Primitive; Osteosarcoma; Phosphoramide Mustards; Rhabdomyosarcoma; Sarcoma, Ewing; Time Factors

1994